Philipp J Hohensinner Selected Research

Philipp J Hohensinner Research Topics

Disease

8	Inflammation (Inflammations) 01/2021 - 03/2011
7	Heart Failure 08/2019 - 09/2010
3	Atherosclerotic Plaque (Atheroma) 12/2021 - 01/2021
3	Cardiovascular Diseases (Cardiovascular Disease) 08/2019 - 03/2011
2	Heart Arrest (Cardiac Arrest) 01/2021 - 10/2020
2	Myocardial Infarction 01/2017 - 06/2006
2	Rheumatoid Arthritis 04/2014 - 12/2011
2	Hypoxia (Hypoxemia) 01/2010 - 06/2006
1	Infections 01/2022
1	Angina Pectoris 01/2021
1	Fabry Disease (Fabry's Disease) 01/2021
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2021
1	Atherosclerosis 01/2021
1	Endotoxemia 09/2019
1	Obesity 01/2019
1	Weight Loss (Weight Reduction) 01/2019
1	Disease Progression 10/2017
1	Fibrosis (Cirrhosis) 10/2017
1	Lung Injury 10/2017
1	Critical Illness (Critically Ill) 12/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 09/2013
1	Autoimmune Diseases (Autoimmune Disease) 12/2011
1	Ataxia Telangiectasia (Louis Bar Syndrome) 12/2011
1	Coronary Disease (Coronary Heart Disease) 06/2011
1	Pathologic Neovascularization 03/2011
1	Necrosis 04/2009
1	Cardiomegaly (Heart Hypertrophy) 04/2006
1	Hypercholesterolemia 04/2006

Drug/Important Bio-Agent (IBA)

6	CytokinesIBA 01/2021 - 06/2006
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 06/2011
3	LigandsIBA 09/2013 - 04/2009
2	MicroRNAs (MicroRNA)IBA 01/2021 - 08/2019
2	Coenzyme A (CoA)IBA 01/2021 - 04/2006
2	DNA (Deoxyribonucleic Acid)IBA 04/2014 - 12/2011
2	Growth Differentiation Factor 15IBA 09/2013 - 06/2011
2	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 09/2013 - 07/2011
2	Chemokine CX3CL1IBA 09/2013 - 12/2012
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2013 - 12/2010
2	ChemokinesIBA 09/2013 - 06/2006
1	Interferon Type IIBA 01/2022
1	Bacterial LysatesIBA 01/2022
1	Antisense OligonucleotidesIBA 12/2021
1	Vasodilator Agents (Vasodilators)IBA 01/2021
1	Nicorandil (SG 75)IBA 01/2021
1	EnzymesIBA 01/2021
1	cytidylyl-(3'-5')-cytidine (CpC)IBA 01/2021
1	globotriaosylceramide (globotriosylceramide)IBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	GalactosidasesIBA 01/2021
1	Trimetazidine (Vastarel)IBA 01/2021
1	NF-kappa B (NF-kB)IBA 01/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2021
1	InflammasomesIBA 01/2021
1	Epinephrine (Adrenaline)FDA LinkGeneric 10/2020
1	Plasminogen Activators (Plasminogen Activator)IBA 09/2019
1	Thromboplastin (Tissue Factor)IBA 09/2019
1	Proteins (Proteins, Gene)FDA Link 09/2019
1	Small Nucleolar RNA (snoRNA)IBA 08/2019
1	Bleomycin (Blenoxane)FDA LinkGeneric 10/2017
1	Matrix Metalloproteinases (MMPs)IBA 10/2017
1	Plasminogen Activator Inhibitor 1IBA 10/2017
1	Simendan (Levosimendan)IBA 01/2017
1	Mitochondrial DNA (mtDNA)IBA 12/2015
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2013
1	pro-brain natriuretic peptide (1-76)IBA 09/2013
1	Phosphotransferases (Kinase)IBA 12/2011
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2011
1	Interleukin-6 (Interleukin 6)IBA 06/2011
1	2- phenyl- 5,5- dimethyltetrahydro- 1,4- oxazineIBA 03/2011
1	Oncostatin MIBA 03/2011
1	Glycoproteins (Glycoprotein)IBA 03/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2011
1	pigment epithelium-derived factorIBA 09/2010
1	2,2'-Dipyridyl (2,2 Bipyridine)IBA 01/2010
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2010
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 01/2010
1	cobaltous chloride (cobalt(II)chloride)IBA 01/2010
1	Monocyte Chemoattractant ProteinsIBA 06/2006
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2006

Therapy/Procedure

1	Therapeutics 01/2021
1	Bariatric Surgery 01/2019